title: Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.
abstract: Hypertrophic cardiomyopathy (HCM), the most common genetic cardiac disorder, is frequently caused by mutations in MYBPC3, encoding cardiac myosin-binding protein C (cMyBP-C). Moreover, HCM is the leading cause of sudden cardiac death (SCD) in young athletes. Interestingly, SCD is more likely to occur in male than in female athletes. However, the pathophysiological mechanisms leading to sex-specific differences are poorly understood. Therefore, we studied the effect of sex and exercise on functional properties of the heart and sarcomeres in mice carrying a MYBPC3 point mutation (G > A transition in exon 6) associated with human HCM. Echocardiography followed by isometric force measurements in left ventricular (LV) membrane-permeabilized cardiomyocytes was performed in wild-type (WT) and heterozygous (HET) knock-in mice of both sex (N = 5 per group) in sedentary mice and mice that underwent an 8-week voluntary wheel-running exercise protocol. Isometric force measurements in single cardiomyocytes revealed a lower maximal force generation (F max) of the sarcomeres in male sedentary HET (13.0 ± 1.1 kN/m(2)) compared to corresponding WT (18.4 ± 1.8 kN/m(2)) male mice. Exercise induced a higher F max in HET male mice, while it did not affect HET females. Interestingly, a low cardiac troponin I bisphosphorylation, increased myofilament Ca(2+)-sensitivity, and LV hypertrophy were particularly observed in exercised HET females. In conclusion, in sedentary animals, contractile differences are seen between male and female HET mice. Male and female HET hearts adapted differently to a voluntary exercise protocol, indicating that physiological stimuli elicit a sexually dimorphic cardiac response in heterozygous MYBPC3-targeted knock-in mice.
authors.affiliation: Department of Physiology, VU University Medical Center, Room B-156, Van der Boechorstraat 7, 1081 BT, Amsterdam, The Netherlands, a.najafi@vumc.nl.
authors.forename: Aref
authors.initials: A
authors.lastname: Najafi
authors.forename: Saskia
authors.initials: S
authors.lastname: Schlossarek
authors.forename: Elza D
authors.initials: ED
authors.lastname: van Deel
authors.forename: Nikki
authors.initials: N
authors.lastname: van den Heuvel
authors.forename: Ahmet
authors.initials: A
authors.lastname: Güçlü
authors.forename: Max
authors.initials: M
authors.lastname: Goebel
authors.forename: Diederik W D
authors.initials: DW
authors.lastname: Kuster
authors.forename: Lucie
authors.initials: L
authors.lastname: Carrier
authors.forename: Jolanda
authors.initials: J
authors.lastname: van der Velden
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D002352:Carrier Proteins / Q000235:genetics*; D002478:Cells, Cultured; D005260:Female; D008297:Male; D051379:Mice; D009154:Mutation; D009200:Myocardial Contraction; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000502:physiology; D005082:Physical Exertion; D012737:Sex Factors; D019210:Troponin I / Q000378:metabolism; D000099163:Myosin Binding Protein C
chemical_list: D002118:Calcium; D002352:Carrier Proteins; D019210:Troponin I; D000099163:Myosin Binding Protein C